ZA201407198B - Methods and compositions for stabilizing dried biological materials - Google Patents
Methods and compositions for stabilizing dried biological materialsInfo
- Publication number
- ZA201407198B ZA201407198B ZA2014/07198A ZA201407198A ZA201407198B ZA 201407198 B ZA201407198 B ZA 201407198B ZA 2014/07198 A ZA2014/07198 A ZA 2014/07198A ZA 201407198 A ZA201407198 A ZA 201407198A ZA 201407198 B ZA201407198 B ZA 201407198B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- methods
- biological materials
- dried biological
- stabilizing
- Prior art date
Links
- 239000012620 biological material Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000000087 stabilizing effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261606577P | 2012-03-05 | 2012-03-05 | |
| EP12158086 | 2012-03-05 | ||
| PCT/NL2013/050139 WO2013133702A1 (en) | 2012-03-05 | 2013-03-05 | Methods and compositions for stabilizing dried biological materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201407198B true ZA201407198B (en) | 2016-02-24 |
Family
ID=49117091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2014/07198A ZA201407198B (en) | 2012-03-05 | 2014-10-03 | Methods and compositions for stabilizing dried biological materials |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9827303B2 (enExample) |
| EP (1) | EP2822540B1 (enExample) |
| JP (1) | JP6253161B2 (enExample) |
| KR (1) | KR102108876B1 (enExample) |
| CN (1) | CN104271119B (enExample) |
| AU (1) | AU2013228096B2 (enExample) |
| BR (1) | BR112014020930A2 (enExample) |
| CA (1) | CA2865551C (enExample) |
| IN (1) | IN2014MN01714A (enExample) |
| WO (1) | WO2013133702A1 (enExample) |
| ZA (1) | ZA201407198B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104274827B (zh) * | 2013-07-01 | 2020-07-14 | 上海贺普药业股份有限公司 | 贺普拉肽的制剂 |
| WO2015097650A1 (en) | 2013-12-23 | 2015-07-02 | Theravectys | Lyophilized lentiviral vector particles, compositions and methods |
| KR102389489B1 (ko) * | 2016-06-16 | 2022-04-22 | 얀센 백신스 앤드 프리벤션 비.브이. | Hiv 백신 제형 |
| EP3586905B1 (en) * | 2017-02-24 | 2023-07-26 | Hisamitsu Pharmaceutical Co., Inc. | Method for producing microneedle device |
| WO2018201154A1 (en) * | 2017-04-28 | 2018-11-01 | Universal Stabilization Technologies, Inc. | Antigenic thermostable polio vaccines & related methods |
| AU2018301395B2 (en) * | 2017-07-11 | 2024-11-14 | Universal Stabilization Technologies, Inc. | Method for Preserving Biological Materials |
| CN111166891B (zh) * | 2018-11-13 | 2022-04-05 | 中国药科大学 | 甘露醇共晶辅料及其制备方法和用途 |
| CN112111609A (zh) * | 2020-10-29 | 2020-12-22 | 上海伯杰医疗科技有限公司 | 一种肠道病毒通用型核酸检测试剂盒 |
| CN114748615A (zh) * | 2022-04-29 | 2022-07-15 | 成都安永鼎业生物技术有限公司 | 一种治疗用重组卡介苗的冻干制剂及其制备方法和用途 |
| CN115089864B (zh) * | 2022-07-14 | 2023-12-29 | 复旦大学 | 一种使用冷冻干燥技术制备可溶性微针贴片的方法 |
| CN116763914B (zh) * | 2023-02-06 | 2024-02-23 | 广东永顺生物制药股份有限公司 | 猪瘟、高致病性猪繁殖与呼吸综合征二联耐热保护剂活疫苗及其制备方法 |
| CN117482072A (zh) * | 2023-11-17 | 2024-02-02 | 上海市浦东新区公利医院(第二军医大学附属公利医院) | 山梨糖醇在制备治疗呼吸道合胞病毒所致疾病的药物中的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2505657A1 (fr) * | 1981-05-13 | 1982-11-19 | Pasteur Institut | Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation |
| JPH0761955B2 (ja) * | 1988-04-28 | 1995-07-05 | 国立予防衛生研究所長 | 凍結乾燥ａ型肝炎ワクチン |
| ATE377428T1 (de) * | 1996-09-26 | 2007-11-15 | Merck & Co Inc | Rotavirus-impfstoff |
| US6210683B1 (en) * | 1997-09-05 | 2001-04-03 | Merck & Co., Inc. | Stabilizers containing recombinant human serum albumin for live virus vaccines |
| EP2420247A1 (en) * | 2000-03-07 | 2012-02-22 | Merck Sharp & Dohme Corp. | Adenovirus formulations |
| KR20030020294A (ko) * | 2000-06-08 | 2003-03-08 | 파우더젝트 백신, 인코포레이티드 | 분말 조성물 |
| GB0020089D0 (en) | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
| FR2814957B1 (fr) * | 2000-10-06 | 2002-12-20 | Aventis Pasteur | Composition vaccinale et procede de stabilisation |
| MXPA06006947A (es) * | 2003-12-17 | 2007-01-26 | Wyeth Corp | Metodos para producir virus de almacenamiento estable y composiciones inmunogenicas de estos. |
| SI1699919T1 (sl) | 2003-12-24 | 2017-07-31 | De Staat der Nederlanden, Vertegenwoordigd Door de Minister Van Volksgezondheid, Welzijn | Respiratorni sincicijski virus z genomsko pomanjkljivostjo komplementarno v trans |
| GB0503337D0 (en) * | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
| TWI398272B (zh) * | 2005-03-08 | 2013-06-11 | Intervet Int Bv | 化學定義的安定劑 |
| ES2776657T3 (es) * | 2005-06-14 | 2020-07-31 | Amgen Inc | Formulaciones de proteínas autotamponantes |
| JP5891175B2 (ja) | 2009-12-11 | 2016-03-22 | バインド セラピューティックス インコーポレイテッド | 治療用粒子の凍結乾燥に対する安定製剤 |
-
2013
- 2013-03-05 WO PCT/NL2013/050139 patent/WO2013133702A1/en not_active Ceased
- 2013-03-05 CA CA2865551A patent/CA2865551C/en active Active
- 2013-03-05 CN CN201380023800.9A patent/CN104271119B/zh not_active Expired - Fee Related
- 2013-03-05 IN IN1714MUN2014 patent/IN2014MN01714A/en unknown
- 2013-03-05 JP JP2014560879A patent/JP6253161B2/ja not_active Expired - Fee Related
- 2013-03-05 AU AU2013228096A patent/AU2013228096B2/en not_active Ceased
- 2013-03-05 US US14/382,258 patent/US9827303B2/en not_active Expired - Fee Related
- 2013-03-05 KR KR1020147024688A patent/KR102108876B1/ko not_active Expired - Fee Related
- 2013-03-05 EP EP13709589.9A patent/EP2822540B1/en not_active Not-in-force
- 2013-03-05 BR BR112014020930A patent/BR112014020930A2/pt active Search and Examination
-
2014
- 2014-10-03 ZA ZA2014/07198A patent/ZA201407198B/en unknown
-
2017
- 2017-10-27 US US15/795,545 patent/US10335479B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20180055924A1 (en) | 2018-03-01 |
| EP2822540A1 (en) | 2015-01-14 |
| JP6253161B2 (ja) | 2017-12-27 |
| KR102108876B1 (ko) | 2020-05-12 |
| AU2013228096B2 (en) | 2017-07-13 |
| IN2014MN01714A (enExample) | 2015-05-29 |
| EP2822540B1 (en) | 2020-04-08 |
| KR20150008848A (ko) | 2015-01-23 |
| US20150030629A1 (en) | 2015-01-29 |
| US9827303B2 (en) | 2017-11-28 |
| JP2015509529A (ja) | 2015-03-30 |
| CN104271119B (zh) | 2018-07-10 |
| BR112014020930A2 (pt) | 2017-06-27 |
| AU2013228096A1 (en) | 2014-09-11 |
| CA2865551A1 (en) | 2013-09-12 |
| CN104271119A (zh) | 2015-01-07 |
| WO2013133702A1 (en) | 2013-09-12 |
| US10335479B2 (en) | 2019-07-02 |
| CA2865551C (en) | 2021-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201405478VA (en) | Stabilizing composition for biological materials | |
| IL272171B (en) | The compositions for the analysis of the interaction between RNA and chromatin, and their uses | |
| GB2518764B (en) | Methods and compositions for RNA-directed target DNA modification | |
| ZA201407198B (en) | Methods and compositions for stabilizing dried biological materials | |
| PL2920149T3 (pl) | Związki 3-aminocykloalkilowe jako inhibitory ror-gamma-t oraz ich zastosowania | |
| ZA201405694B (en) | Virus like particle composition | |
| ZA201504131B (en) | Fragrance materials | |
| IL237309A0 (en) | Benzocyclooctyne compounds and uses thereof | |
| IL238416A0 (en) | Preparations and methods for the treatment of diseases caused by protein pathology | |
| AP2014007835A0 (en) | Oxazolidin-2-one compounds and uses thereof as P13KS inhibitors | |
| ZA201408594B (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
| EP2935226A4 (en) | HETEROARYL COMPOUNDS AND USES THEREOF | |
| EP2868312A4 (en) | CAPILLARY DYE COMPOSITION | |
| GB201315350D0 (en) | Methods and compositions | |
| GB201315347D0 (en) | Methods and compositions | |
| EP2874641A4 (en) | COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF | |
| PT2851083T (pt) | Composição proteica resistente à esterilização por radiação | |
| PL2882708T3 (pl) | Nowe związki i ich zastosowania | |
| ZA201502703B (en) | Novel flavonoid compounds and uses thereof | |
| GB201222736D0 (en) | Composition and process | |
| PL2830587T3 (pl) | Kompozycja o balansującym i ochronnym wpływie na skórę | |
| GB201215379D0 (en) | Improved materials | |
| GB201215381D0 (en) | Improved materials | |
| DK2822540T3 (da) | Fremgangsmåder og sammensætninger til stabilisering af tørrede biologiske materialer | |
| GB201222342D0 (en) | Compounds and uses thereof |